• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术后克罗恩病复发的预测因素有哪些?

What are the predictors for recurrence of Crohn's disease after surgery?

机构信息

Gastrointestinal Surgery Unit, Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University.

Department of General Surgery, VKV Koc University Hospital, VKV Koc University Medicine School.

出版信息

Medicine (Baltimore). 2021 Apr 9;100(14):e25340. doi: 10.1097/MD.0000000000025340.

DOI:10.1097/MD.0000000000025340
PMID:33832109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8036018/
Abstract

Surgical resection is an unavoidable part of the current treatment options for Crohn's disease (CD), and more than half of patients develop recurrence. The aim of this study was to investigate the predictors for recurrence in the long-term follow-up of CD patients after surgery.Medical records of consecutive CD patients who were operated on between January 2003 and January 2015 were retrospectively analyzed. Data including demographic and clinical characteristics of the patients were recorded. Recurrence was evaluated based on the Crohn's Disease Activity Index or endoscopic findings.The majority of 112 patients were males (n = 64, 57.1%), and 61 (54.4%) of them were active smokers. The median follow-up was 113 (range: 61-197) months. Disease recurrence occurred in 16 (14.3%) patients at a median of 13.5 months. The endoscopic recurrence rate was 8% (n = 9) at 1 year, 12.5% (n = 14) at 5 years, and 13.4% (n = 15) at 10 years. One (0.9%) patient underwent colonoscopic balloon dilatation at 1 year, and 7 (6.3%) patients needed re-resection at a median of 36 months. The age of the patient at the time of diagnosis (P = .033), penetrating disease behavior (P = .011), intra-abdominal abscess (P = 0.040) and, concomitant fistula and intra-abdominal abscess (P = .017) were associated with disease recurrence.Our study results suggest that the patients' age at the time of diagnosis, penetrating disease, intra-abdominal abscess, and concomitant fistula and abscess are the risk factors for CD recurrence after surgery.

摘要

手术切除是目前治疗克罗恩病(CD)的不可避免的一部分,超过一半的患者会复发。本研究旨在探讨 CD 患者手术后长期随访中复发的预测因素。

回顾性分析 2003 年 1 月至 2015 年 1 月期间连续接受手术的 CD 患者的病历。记录患者的人口统计学和临床特征数据。根据克罗恩病活动指数或内镜检查结果评估复发。

112 例患者中,大多数为男性(n=64,57.1%),61 例(54.4%)为吸烟者。中位随访时间为 113(范围:61-197)个月。16 例(14.3%)患者在中位时间 13.5 个月时发生疾病复发。内镜复发率为 1 年时 8%(n=9),5 年时 12.5%(n=14),10 年时 13.4%(n=15)。1 例(0.9%)患者在 1 年内接受结肠镜球囊扩张,7 例(6.3%)患者在中位时间 36 个月时需要再次切除。患者诊断时的年龄(P=0.033)、穿透性疾病行为(P=0.011)、腹腔脓肿(P=0.040)和同时存在瘘管和腹腔脓肿(P=0.017)与疾病复发相关。

我们的研究结果表明,患者诊断时的年龄、穿透性疾病、腹腔脓肿以及同时存在瘘管和脓肿是 CD 手术后复发的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/8036018/acc4f91f9078/medi-100-e25340-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/8036018/acc4f91f9078/medi-100-e25340-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/8036018/acc4f91f9078/medi-100-e25340-g001.jpg

相似文献

1
What are the predictors for recurrence of Crohn's disease after surgery?手术后克罗恩病复发的预测因素有哪些?
Medicine (Baltimore). 2021 Apr 9;100(14):e25340. doi: 10.1097/MD.0000000000025340.
2
A Reappraisal of Outcome of Elective Surgery After Successful Non-Operative Management of an Intra-Abdominal Abscess Complicating Ileocolonic Crohn's Disease: A Subgroup Analysis of a Nationwide Prospective Cohort.成功非手术治疗合并回肠结肠克罗恩病的腹腔脓肿后择期手术结局再评估:一项全国前瞻性队列的亚组分析。
J Crohns Colitis. 2021 Mar 5;15(3):409-418. doi: 10.1093/ecco-jcc/jjaa217.
3
Long-term outcomes of intestinal penetrating Crohn's disease following successful nonoperative management.经成功非手术治疗后肠穿透性克罗恩病的长期结局。
Eur J Gastroenterol Hepatol. 2024 Jul 1;36(7):867-874. doi: 10.1097/MEG.0000000000002775. Epub 2024 Apr 5.
4
Factors associated with operative recurrence early after resection for Crohn's disease.克罗恩病切除术后早期手术复发的相关因素。
J Gastrointest Surg. 2011 Aug;15(8):1354-60. doi: 10.1007/s11605-011-1552-4. Epub 2011 May 28.
5
Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn's Disease?戒烟是否会降低克罗恩病初次回肠结肠切除术后的手术复发率?
Dis Colon Rectum. 2020 Feb;63(2):200-206. doi: 10.1097/DCR.0000000000001547.
6
Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.阳性组织学炎症切缘与克罗恩病患者接受回肠结肠切除术时发生腹腔内感染性并发症的风险增加相关。
Dis Colon Rectum. 2012 Nov;55(11):1125-30. doi: 10.1097/DCR.0b013e318267c74c.
7
[Risk factors of early surgical intervention in Crohn's disease patients with spontaneous intra-abdominal abscess].[克罗恩病合并自发性腹腔内脓肿患者早期手术干预的危险因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Dec 25;19(12):1379-1383.
8
A Practical Predictive Index for Intra-abdominal Septic Complications After Primary Anastomosis for Crohn's Disease: Change in C-Reactive Protein Level Before Surgery.克罗恩病一期吻合术后腹腔感染并发症的实用预测指标:术前C反应蛋白水平的变化
Dis Colon Rectum. 2015 Aug;58(8):775-81. doi: 10.1097/DCR.0000000000000414.
9
The operative risk and natural history after the diagnosis of ileal penetrating Crohn's disease.回肠穿透性克罗恩病诊断后的手术风险及自然病程
Eur J Gastroenterol Hepatol. 2018 May;30(5):539-545. doi: 10.1097/MEG.0000000000001091.
10
Similar outcomes of surgical and medical treatment of intra-abdominal abscesses in patients with Crohn's disease.克罗恩病患者腹腔脓肿采用手术和内科治疗的效果相似。
Clin Gastroenterol Hepatol. 2012 Apr;10(4):400-4. doi: 10.1016/j.cgh.2011.11.023. Epub 2011 Dec 7.

引用本文的文献

1
Effect of Kono-S anastomosis on reducing postoperative recurrence rates in Crohn's disease: a systematic review and meta-analysis.Kono-S 吻合术对降低克罗恩病术后复发率的影响:系统评价和荟萃分析。
Tech Coloproctol. 2024 Sep 18;28(1):127. doi: 10.1007/s10151-024-02991-7.
2
Small bowel pyloric metaplasia is associated with lower rates of earlier recurrence of Crohn's disease after resection.小肠幽门化生与克罗恩病切除术后早期复发率降低有关。
Hum Pathol. 2024 Sep;151:105629. doi: 10.1016/j.humpath.2024.105629. Epub 2024 Jul 17.
3
Management of Post-Operative Crohn's Disease: Knowns and Unknowns.
术后克罗恩病的管理:已知与未知
J Clin Med. 2024 Apr 16;13(8):2300. doi: 10.3390/jcm13082300.
4
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial.在一项随机 3 期临床试验中,维持 risankizumab 可维持克罗恩病患者的诱导缓解。
J Crohns Colitis. 2024 Mar 1;18(3):416-423. doi: 10.1093/ecco-jcc/jjad168.